FDA Inspection
Exela Pharma Sciences LLCExela Pharma Sciences LLC – FDA Inspection, Nov 15, 2024
Record Details
This FDA Inspection record concerns Exela Pharma Sciences LLC, with an inspection on November 15, 2024, covering drugs.
- Company
- Exela Pharma Sciences LLC
- Inspection Date
- November 15, 2024
View Company Profile
ID · c49bbdca-1ca9-482e-af5f-49658d2feb1c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1256957
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Exela Pharma Sciences LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2019 | VAI | Atlanta District Office | Generic Drug Evaluation |
| December 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 27, 2017 | Not classified | Atlanta District Office |
Other documents for Exela Pharma Sciences LLC
- FDA Inspection 1096634 - 2019-07-18
- FDA Inspection 1084304 - 2019-03-29
- FDA Inspection 1081405 - 2018-12-19
- FDA Inspection 1067755 - 2018-09-11
- FDA Inspection 1032076 - 2017-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.